There were 1,074 press releases posted in the last 24 hours and 441,090 in the last 365 days.

TriNet Insights Presents: Navigating Uncertainties to Reach the Next Levels for Midsize Biotech Companies


/EINPresswire.com/ -- SAN DIEGO, CA--(Marketwired - August 11, 2016) -

WHO:
Craig Shimasaki, Ph.D., MBA is president & CEO of Moleculera Labs, an autoimmune neurobiology company. He is a scientist and serial entrepreneur with over 32 years of biotechnology industry experience. In addition to co-founding three companies, he is the author and editor of two books -- "The Business of Bioscience: What Goes into Making a Biotechnology Product" and "Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies." He is an adjunct professor at the University of Oklahoma, Price School of Business, where he teaches biotechnology entrepreneurship.

WHAT:
Established biotech companies deal with challenges that are unique and different from those they confronted when they were start-ups.

In this free event, Dr. Shimasaki will share his experiences as an entrepreneur in the biotech industry. He will give tips for how to avoid some of the most daunting challenges biotech companies face, such as:

  • How to manage cash consumption for product development.
  • Dealing with the uncertainty inherent in preclinical and clinical testing outcomes.
  • Moving beyond just generating revenue to turning a profit.
  • Avoiding unexpected pitfalls.
  • Preventing catastrophes while preparing for uncertainty.

Complimentary lunch will be served.

WHEN:
Wednesday, Aug. 17, 2016
11:30 a.m. - 1 p.m. PT

WHERE:
greenACRE Campus Pointe: Brian Malarkey's eatery
10300 Campus Point Dr.
San Diego, CA 92121

REGISTER:
RSVP here; space is limited.

CONTACT:
Jock Breitwieser
TriNet
Jock.Breitwieser@trinet.com
510.875.7250


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.